Showing results (1-10 of 321) with videos related to
Sort By:
Pageof 33
Future Cardiology|April 18, 2009
Inflammation and cardiovascular risk. Vijay Nambi speaks to Christine Forder, commissioning editorVijay NambiCurrent Atherosclerosis Reports|February 25, 2005
The use of myeloperoxidase as a risk marker for atherosclerosisVijay NambiMethodist Debakey Cardiovascular Journal|November 20, 2010
Coronary heart disease risk stratification: pitfalls and possibilitiesSmita Negi, Vijay NambiCurrent Atherosclerosis Reports|August 7, 2004
ASCOT-LLA and the primary prevention of coronary artery disease in hypertensive patientsVijay Nambi, Christie M BallantyneCurrent Atherosclerosis Reports|September 20, 2007
The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosisSalim S Virani, Vijay NambiCurrent Opinion in Nephrology and Hypertension|June 29, 2023
Biomarker guided management of hypertensionPrasanti Alekhya Kotta, Vijay NambiCurrent Atherosclerosis Reports|January 28, 2012
The role of carotid intimal thickness and plaque imaging in risk stratification for coronary heart diseaseSmita I Negi, Vijay NambiExpert Review of Molecular Diagnostics|November 5, 2004
Biomarkers of cardiac diseaseA J Marian, Vijay NambiCurrent Atherosclerosis Reports|August 12, 2006
Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular eventsVijay Nambi, Christie M BallantyneWorld Journal of Surgery|March 28, 2007
Role of biomarkers in developing new therapies for vascular diseaseVijay Nambi, Christie M BallantynePageof 33